Christopher P. Meenan,C. Lowell Parsons,Daniel Vickery
申请号：
US16488628
公开号：
US20200113975A1
申请日:
2018.02.27
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides a method for treating and/or ameliorating a disorder of the lower urinary tract, comprising administering a composition comprising a glucagon like peptide 2 (GLP-2) receptor agonist to a patient in need thereof in an amount sufficient to treat and/or ameliorate the disorder of the lower urinary tract.
